CAS: 1086062-66-9 - Omipalisib
Fórmula:C25H17F2N5O3S
InChI:InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3
Clave InChI:InChIKey=CGBJSGAELGCMKE-UHFFFAOYSA-N
SMILES:O=S(=O)(NC=1C=C(C=NC1OC)C=2C=CC3=NC=CC(C=4C=NN=CC4)=C3C2)C5=CC=C(F)C=C5F
- Sinónimos:
- 2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
- Benzenesulfonamide, 2,4-difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]-
- Gsk 2126458
- Gsk 458
- Gsk2126458
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
GSK-2126458 REF: AN-AG008TGQCAS: 1086062-66-9 | 98% | A consultar | Mié 15 May 24 | |
GSK2126458 REF: 7W-GW9665CAS: 1086062-66-9 | - - - | 371,00 €~819,00 € | Mié 22 May 24 | |
Omipalisib REF: TM-T1861CAS: 1086062-66-9 | 99.8% | 62,00 €~417,00 € | Mié 22 May 24 | |
GSK 2126458 REF: TR-G797500CAS: 1086062-66-9 | - - - | 116,00 €~206,00 € | Mar 28 May 24 | |
GSK 2126458 REF: 3D-FD43337CAS: 1086062-66-9 | Min. 98 Area-% | 74,00 €~632,00 € | Mar 28 May 24 |
GSK-2126458
Ref: AN-AG008TGQ
2mg | 107,00 € | |
5mg | 159,00 € | |
10mg | 200,00 € | |
25mg | 618,00 € | |
50mg | A consultar |
Ref: 7W-GW9665
1mg | 371,00 € | |
5mg | 548,00 € | |
10mg | 819,00 € |
Omipalisib
- Inhibidores
- Autofagia
- Señalización PI3K / Akt / mTOR
- PI3K
- Ver más categorías
- mTOR
Ref: TM-T1861
5mg | 62,00 € | |
10mg | 94,00 € | |
25mg | 172,00 € | |
50mg | 272,00 € | |
100mg | 417,00 € | |
1ml*10 (DMSO) | 68,00 € |
GSK 2126458
Producto controladoRef: TR-G797500
1mg | 116,00 € | |
10mg | 206,00 € |
GSK 2126458
Ref: 3D-FD43337
5mg | 74,00 € | |
10mg | 120,00 € | |
25mg | 243,00 € | |
50mg | 406,00 € | |
100mg | 632,00 € |